We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 133 for:    color II

Color Synbiotics Study

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01813175
First Posted: March 18, 2013
Last Update Posted: September 7, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Danone Asia Pacific Holdings Pte, Ltd.
  Purpose
This study is initiated to investigate the effect of infant formula with added specific synbiotics mixture on proportion of beneficial bacteria.

Condition Intervention
Beneficial Bacteria in Gut Other: Regular non-hydrolysed cow's milk I Other: Regular non-hydrolysed cow's milk II Other: Regular non-hydrolysed cow's milk - control

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Other
Official Title: Randomised, Controlled, Double-blind Exploratory Study to Investigate the Effect of Specific Synbiotics Mixtures on Gut Microbiota Composition in Healthy Infants.

Further study details as provided by Danone Asia Pacific Holdings Pte, Ltd.:

Primary Outcome Measures:
  • Change of Baseline proportion of beneficial bacteria at week 6 in interventional group compared to the change in control group [ Time Frame: baseline, week 6 ]

Secondary Outcome Measures:
  • Change of proportion of baseline beneficial bacteria at week 6 in interventional group I compared to the change in control group [ Time Frame: baseline, week 6 ]
  • Change of Baseline proportion of beneficial bacteria at week 6 in interventional group II compared to the change in control group [ Time Frame: baseline, week 6 ]

Enrollment: 290
Study Start Date: May 2013
Study Completion Date: July 2016
Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Intervention Group I
Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture I
Other: Regular non-hydrolysed cow's milk I
Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture I
Active Comparator: Interventional Group II
Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture II
Other: Regular non-hydrolysed cow's milk II
Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture II
Placebo Comparator: Control Group
Regular non-hydrolysed cow's milk based infant formula
Other: Regular non-hydrolysed cow's milk - control
Regular non-hydrolysed cow's milk based infant formula without synbiotics mixture
No Intervention: Reference Group
Exclusively breast-fed infants

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   43 Days to 65 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy term infants (gestational age ≥ 37 1/7 and ≤ 41 6/7 weeks) aged 46 - 65 days (inclusive) at entry into the study
  • Fully formula fed for at least one week (not applicable for the breastfeeding reference group since these infants must be exclusively breastfed before and throughout the study)
  • Parents' or legal guardian's written informed consent

Exclusion Criteria:

  • Exclusion criteria for run-in period (visit 1, screening) are:
  • Being weaned before inclusion (introduction of any other foods other than formula or human milk)
  • Moderate or severe acute malnutrition, defined as weight-for-age and sex below -2 z-scores of the median WHO growth standards
  • Medical condition for which a special diet other than standard (non hydrolised) cow's milk-based infant formula is required
  • Known congenital diseases or malformations which could interfere with the study (e.g. gastrointestinal malformations, congenital immunodeficiency), as per investigator's clinical judgement
  • Use of systemic antibiotics or anti-mycotic drugs in the 4 weeks prior to entry into the study
  • Received Inactivated Poliovirus Vaccine (IPV) or Rotavirus Vaccine (RV) prior to entry into the study
  • Gastroenteritis or diarrhoea in the last two weeks prior to entry into the study
  • Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study
  • Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01813175


Locations
Thailand
Thammasat Hospital
Klong Luang, Pathumthani, Thailand
King Chulalongkorn Memorial Hospital
Bangkok, Thailand
Phramongkutklao Hospital
Bangkok, Thailand
Sponsors and Collaborators
Danone Asia Pacific Holdings Pte, Ltd.
  More Information

Responsible Party: Danone Asia Pacific Holdings Pte, Ltd.
ClinicalTrials.gov Identifier: NCT01813175     History of Changes
Other Study ID Numbers: COL.1.C.A
First Submitted: March 12, 2013
First Posted: March 18, 2013
Last Update Posted: September 7, 2017
Last Verified: September 2017